๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Long-term results of a randomized trial comparing cisplatin with cisplatin and cyclophosphamide with cisplatin, cyclophosphamide, and adriamycin in advanced ovarian cancer

Book ID
119054181
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
325 KB
Volume
45
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Treatment of advanced ovarian cancer: A
Treatment of advanced ovarian cancer: A randomised trial comparing adriamycin or 4โ€ฒepi-adriamycin in combination with cisplatin and cyclophosphamide
โœ Bezwoda, W. R. ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'

Treatment of advanced ovarian cancer wit
Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: Effect of treatment and incidence of intracranial metastases
โœ G. Thomas Budd; Kenneth D. Webster; Ronald R. Reimer; Pierre Martimbeau; Robert ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 324 KB

A retrospective analysis of 42 patients with stage 111, IV, or recurrcnt epithelial ovarian carcinoma treated with monthly cisplatin, Adriamycin, and cyclophosphamide (PAC) was made. Of 36 patients with measurable disease, 18 (50%) achieved a clinical complete response (CR) and 12 (33%) achieved a p